American Association for the Advancement of Science, Science Translational Medicine, 548(12), 2020
DOI: 10.1126/scitranslmed.aay5691
Full text: Unavailable
Metabolic reprogramming with a GSK3β inhibitor corrects neutrophil dysfunction and improves antifungal function in mouse models of kidney disease.